Q1 2025 · 13F-HR
Matrix Capital Management Company, LPholdings as filed
Filed 2025-05-14 · accession 0001172661-25-001886
$347.2M
Reported value
4
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G39387108 | GFS | GLOBALFOUNDRIES INC | $257.1M | 74.0% | 6,964,952 | Common | SOLE |
| 05153U107 | AURA | AURA BIOSCIENCES INC | $40.6M | 11.7% | 6,922,870 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $27.4M | 7.88% | 2,486,184 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $22.2M | 6.39% | 13,959,973 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.